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Abstract
Background & objectives: The present study was designed to determine possible contributory impact
of malaria infection on some biochemical markers in subjects with HIV co-infection in order to know
if they are adverse or protective.
Methods:  Participants were recruited at the Voluntary Counseling and Testing Unit, Nnamdi Azikiwe
University Teaching Hospital, Nnewi, Nigeria and grouped into: (i) Malaria and HIV co-infection
group (n = 45); and (ii) HIV infected group without concurrent malaria infection (n = 57). Standard
laboratory methods were used for the HIV and Plasmodium falciparum antigen screening, malaria
parasite density, CD4+ T-cell count, packed cell volume, white blood cell count, serum iron and
albumin concentrations.
Results: The results showed that serum iron and albumin were significantly reduced and raised respec-
tively in ‘Malaria–HIV co-infection group’ compared with ‘HIV infection group’ (p <0.05 and p <0.05).
A positive association was observed between age and serum iron concentration in malaria and HIV
co-infected group (r = 0.580; p <0.05) while negative associations were observed between PCV and
serum iron (r = – 0.388; p <0.05) and between CD4+ T-cells and serum iron concentration (r = – 0.362;
p<0.05) in malaria and HIV co-infected group.  The CD4+ T-cell count, WBC count, PCV were not
significantly different between the Malaria-HIV co-infection group and HIV infection group.
Interpretation & conclusion: In the present study serum iron and albumin concentrations were the most
sensitive indicators that showed the contributory impact of malaria infection on biochemical index
in HIV co-infected subjects. The findings suggest that at the defined stage of HIV infection in the
present study, malaria co-infection may moderate the impact of HIV infection on iron metabolism and
hepatic synthesis of albumin.
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Introduction
Malaria is endemic in Nigeria with stable transmis-
sion over the year and high prevalence of asymptom-
atic malaria has been reported in pregnant women in
this region1,2. The spread of human immunodefi-
ciency virus (HIV) is also high within this area3.
Thus, we have shown evidence of malaria-HIV co-in-
fection among the populace with prevalence of ma-
laria parasitaemia being higher amongst symptomaticJ  VECTOR  BORNE  DIS  45, JUNE 2008 152
HIV infected subjects3. The advent of HIV infection
in the sub-Saharan Africa has also led to high preva-
lence of malaria infection in HIV subjects in areas
with stable transmission3,4 and unstable transmis-
sion5,6. Presentation of severe malaria has been ob-
served in HIV subjects with CD4 + T-cell count less
than 200 x 106 cells/L7. The risk was shown to be
higher in non-immune malaria subjects who usually
present with a high parasite and WBC counts7. In our
recent observation3, we reported that prevalence of
malaria infection is tripled amongst symptomatic
HIV-infected subjects, however, the prevalence
amongst the asymptomatic HIV-infected subjects
was similar to that expressed by the apparently
healthy HIV seronegative individuals within the
same area. Hence, the present study was designed to
determine the possible contributory impact of malaria
parasitaemia on some biochemical markers in sub-
jects with HIV co-infection.
Material & Methods
Subjects participated in the study were recruited at the
Voluntary Counseling and Testing (VCT) Unit,
Nnamdi Azikiwe University Teaching Hospital
(NAUTH), Nnewi, Nigeria. At the VCT, individuals
are counseled on HIV infection, health implications
and management of a positive HIV test. While re-
cruiting at the VCT, individuals were screened for
HIV infection, Plasmodium falciparum antigen and
malaria parasite detection. The participants with
positive HIV test were further staged into asymptom-
atic (stage-1) and symptomatic (stage-2) using the
World Health Organization (WHO) guidelines on
HIV staging. Stage-3 and stage-4 individuals were
excluded in the present study. The recruited partici-
pants were not on anti-retroviral therapy. Based on
the above screening result, the participants were sub-
sequently divided into following groups.
Malaria and HIV co-infected group: Consists of 45
participants aged 36 ± 10 years (male =15, females =
30) with both malaria and HIV co-infection and 28 of
these participants presented with ‘symptomatic HIV
co-infection’ while the remaining 17 participants pre-
sented with ‘asymptomatic HIV co-infection’.
HIV infected group: Consists of 57 participants aged
37 ± 10 years (male = 20, females = 37) with HIV in-
fection without concurrent malaria infection and 30
of these participants presented with ‘symptomatic
HIV infection’ while the remaining 27 participants
presented with ‘asymptomatic HIV infection’.
Blood samples collected were also used for malaria
parasite density determination; CD4+ T-cell count,
packed cell volume (PCV), white blood cell count
(WBC), serum iron and albumin levels. The study
was carried out between the month of May and
August, a predominantly rainy season in Nigeria. The
participants gave informed consent while the
NAUTH ethical committee approved the study
design.
Method for HIV screening was as previously de-
scribed3. Method for P. falciparum histidine rich
protein seroreactivity and parasite density was as
previously described2,3.  Bromocresol Green (BCG)
method was used to determine serum albumin con-
centration.
Determination of the packed cell volume:  Anti-co-
agulated (EDTA) blood sample from each participant
was aspirated into micro-haematocrit capillary tubes.
One end of the capillary tube was subsequently sealed
and placed in the micro-haematocrit centrifuge. A
constant packing of the red blood cells was achieved
with a centrifugation speed of 1200x g for 3 min. The
PCV was measured and reported as a ratio of the
whole blood volume in litre/litre.
Determination of CD4+
 T-cells count by Cyflow SL
Green: About 50 μl of whole blood in EDTA anti-
coagulant was dispensed into a partec test tube and
10 ml of CD4 PE antibody was added. The reaction
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10–15 min. After the incubation, 800 μl of the already
prepared diluted buffer was added to each reaction
tube and vortexed.  The partec tubes containing these
reactions were plugged in position in the Cyflow SL
Green (Partec, Germany), which has already been
connected to flow max software, CD4 count template
data file and CD4 count instrument. The test was run
on the Cyflow for 90 sec. The results were displayed
as histogram and printed. The CD4+ T-cell count was
read off the histogram correcting for the dilution
factor.
Serum iron determination by colorimetric method:
The procedure was as described by the manufacturer
of the kit (Chromatest, Barcelona, Spain). In brief,
200 μl of the sample from each participant was put in
appropriately labeled test tube containing 1.0 ml of
working solution [containing one part of chromogen
solution (ferrozine 40 mmol/L and sodium acetate
400 mmol/L) and four parts of buffer/reductant solu-
tion (Guanidine chloride 1.0 mol/L; hydroxylamine
0.6 mol/L; acetate buffer 400 mmol/L pH 4.0; teepol
mixture)]. Similar procedure was used for the reagent
blank and standard test tubes, except that the sample
blank was prepared with addition of 1.0 ml of the
buffer/reductant solution. The reactions were incu-
bated at room temperature for 5 min, after which the
absorbance of the sample blank was read at 560 nm
against distilled water while the absorbance of the
sample tests and standards were read at 560 nm
against reagent blank. Subsequently, the concentra-
tion of serum iron was calculated.
Determination of WBC counts using tuerk’s solution:
Into appropriately labeled test tubes containing
950 μl of tuerk’s solution (2% glacial acetic acid and
50 μl of gentian violet), 50 μl of EDTA anti-coagu-
lated blood sample of each participant was added re-
spectively. The solution was allowed to stand for 5
min and through capillary action was loaded unto the
new improved neurber chamber. The population of
WBC in the four corner cells was read under the mi-
croscope using  x10 objective lens. The amount of
WBC was then calculated for each participant adjust-
ing for the dilution.
Statistical analysis: The variables were expressed
as mean (± SD). The independent student t-test was
used to assess significant mean differences. The
Spearman’s correlation coefficient was used to assess
the level of association between two variables. Sig-
nificant level were considered at <0.05 and <0.01.
Results
The mean  serum iron concentration  in malaria and
HIV co-infected group (107.5 ± 53.5) was signifi-
cantly lower than that of in HIV infected group (151.9 ±
79.3) without concurrent malaria infection (p <0.05).
Similarly, the mean serum albumin concentration  in
malaria and HIV co-infected group (42 ± 9.6) was
significantly higher than the HIV infected group
(38.4 ± 7.5) without concurrent malaria infection
(p <0.05). On the contrary, WBC count, CD4+ T-cell
count and PCV were similar in both groups (p >0.1
in each case). The blood P. falciparum parasite den-
sity in the malaria and HIV co-infected group was
667 x 103 ± 463 x 103 (Table 1).
The mean serum iron concentration  in participants
with malaria and asymptomatic HIV co-infection was
significantly lower compared to that of participants
with asymptomatic HIV infection without concurrent
malaria infection (p <0.01). Similarly, the mean se-
rum albumin concentration in participants with ma-
laria and asymptomatic HIV co-infection was signifi-
cantly higher than that of participants with asymp-
tomatic HIV infection without concurrent malaria in-
fection (p <0.05). Other parameters were similar be-
tween both groups (Table 1).
When comparisons were made between the malaria
and symptomatic HIV co-infected participants and
symptomatic HIV infected participants without con-
current malaria infection, no significant mean differ-
ence was observed between both groups (Table 1).J  VECTOR  BORNE  DIS  45, JUNE 2008 154
Furthermore, sex distribution of the evaluated param-
eters showed no significant differences irrespective
of the group.
A positive association was observed between age and
serum iron concentration in malaria and HIV co-in-
fected group (r = 0.580; p <0.05). However, negative
associations were observed between PCV and serum
iron (r = – 0.388; p <0.05) and between CD4+ T-cells
and serum iron concentration (r = – 0.362; p <0.05)
in malaria and HIV co-infected group. Positive asso-
ciations were observed between CD4+ T-cell count
and serum iron (r = 0.487; p <0.05); and between
CD4+ T-cells and serum albumin (r = 0.301; p <0.01)
in HIV infected group without concurrent malaria in-
fection.
Discussion
The present study was designed to assess the con-
tributory impact of malaria infection in subjects with
HIV co-infection. The serum iron concentration was
the most sensitive indicator of possible impact of
malaria infection in subjects with HIV co-infection.
The study clearly revealed that serum iron was re-
duced in malaria and HIV co-infected group com-
pared with HIV infected group without concurrent
malaria infection. The reduced serum iron concentra-
tion was also particularly true amongst the malaria
and asymptomatic HIV co-infected participants but
not truly in malaria and symptomatic HIV co-infected
participants.
The positive association observed between serum
iron and age in malaria and HIV co-infected group,
might be an indication that the reduced serum iron
might be more pronounced with age in such individu-
als with co-infection. This finding is with respect to
a malaria endemic area with stable transmission
throughout the year.
The negative association observed between serum
iron and PCV and on the other hand between serum
iron and CD4+ T-cell count, in malaria and HIV co-
infected group calls for critical analysis and interpre-
tation. This is because of the possible implications
and impact of free iron on health. CD4+ T-cell count
has been used generally to define stability of HIV in-
fected subjects with counts of below 200 regarded as
indication of poor prognosis. Hence, the result of
negative association between serum iron concentra-
tion and CD4+ T-cell count could well deduce that
reduced serum iron in malaria-HIV co-infection is
indicative of good prognosis.
In HIV infection, serum ferritin level has been shown
to be positively associated with viral load8.  In a study
Table 1. Mean (± SD) blood concentrations of WBC,
PCV, CD4+ T-cells, P. falciparum density and
serum concentrations of iron and albumin
in study subjects
Parameters HIV- Malaria-HIV p-value
infected  co-infected
Symptomatic &   n = 57          n = 42
asymptomatic
WBC (x106/L) 4.16±1.24 3.93±1.25 >0.1
PCV (L/L) 0.32±0.04 0.32±0.08 >0.1
CD4+ T-cells (/mm3) 285±124 292± 149 >0.1
Serum iron (μg/dL) 151.8±79.3 107.5±53.5 <0.05
Pf density (x103/L) – 667±463 nc
Serum albumin (g/L) 38.4±7.5 42±9.6 <0.05
Asymptomatic (n=26)( n=18)
WBC (x106/L) 4.18±1.23 4.02±1.19 >0.1
PCV (L/L) 0.34±0.04 0.35±0.08 >0.1
CD4+ T-cells (/mm3) 319±81 326±157 >0.1
Serum iron (μg/dL) 133.4±53.3 81.2±36.7 <0.01
Pf density (x103/L) – 803±526 nc
Serum albumin (g/L) 37.2±5.6 43.1±6.5 <0.05
Symptomatic (n=30)( n=28)
WBC (x106/L) 4.14±1.27 3.89±1.30 >0.1
PCV (L/L) 0.31±0.04 0.30±0.07 >0.1
CD4+ T-cells (/mm3) 257±148 266±140 >0.1
Serum iron (μg/dL) 171.7±98.6 127.3±56.4 >0.1
Pf density (x103/L) – 604±440 nc
Serum albumin (g/L) 39.3±8.6 41.5±10.9 >0.1
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elsewhere amongst asymptomatic malaria subjects
serum iron level has been shown to be similar to that
observed in uninfected control subjects9. In another
study amongst apparently healthy individuals in
Nigeria with malaria parasitaemia, serum iron level
was found to be similar in both the parasitaemic and
aparasitaemic apparently healthy individuals10.  A
possible role has been defined for iron in HIV infec-
tion8 and serum ferritin has been reported to be lower
in HIV infected subjects compared with malaria
parasitaemic subjects11.
Thus, the finding in the present study and those re-
ported above could suggest that the possible source
of increased serum iron in HIV infection may be
depletion of iron store. But such depletion of iron
store and release into circulation may be disrupted in
cases of malaria co-infection. This process of deple-
tion of iron store may be reversed in cases of concur-
rent malaria infection, thus favouring reduced iron in
transport with consequent increase in storage. How-
ever, it may be necessary to check the total iron bind-
ing capacity in these individuals as it may help to
further understand the metabolic mechanism of iron.
This is because when the malaria-HIV co-infected
group was further considered based on HIV staging
the serum iron remained reduced in asymptomatic but
not in symptomatic HIV co-infected participants.
Studies elsewhere have shown occurrence of severe
malaria in non-immune subjects with HIV co-infec-
tion with CD4+ T-cell count of below 200 cells5.
However, they were unable to observe severe malaria
in subjects with HIV co-infection from endemic
area5. In their report, increase in WBC and parasite
counts were only observed in non-immune subjects
with HIV co-infection. In an another report from
Malawi, CD4 cell count was found to be moderately
but inconsistently associated with malaria para-
sitaemia12.
In the present study, the mean CD4+ T-cell count was
neither below 200 cells nor was there any significant
difference in means among subjects with malaria-
HIV co-infection and HIV infection alone. This may
be an indication that malaria infection in these sub-
jects did not have any contributory suppressive im-
pact on the CD4+ T-cells count or that T-cell function
is still fairly well.  Similarly, we have observed that
neutrophil ingestion of nitroblue tetrazolium was
impaired in both HIV-malaria co-infection and HIV
infection alone, however, no contributory impairment
due to malaria was noticed13.
A striking observation is the significant increase in
serum albumin in malaria and HIV co-infected group
which could be an indication that malaria infection in
endemic area may interact to reverse the progressive
distortion of synthesis of albumin by the liver during
HIV infection. This observation may not be attributed
to dehydration considering the PCV observed in same
subjects. This calls for further investigation because
serum albumin has a strong prognostic value in HIV
infection14,15.
In the present study, serum iron and albumin concen-
trations were the most sensitive indicators that
showed the contributory impact of malaria infection
on biochemical index in HIV co-infected subjects.
The findings suggest that at the defined stage of HIV
infection in the present study, malaria co-infection
may moderate the impact of HIV infection on iron
metabolism and hepatic synthesis of albumin. It could
be that for the CD4+ T-cell count observed, certain
level of immune regulation may still exist in these
subjects and ability to keep in check the level of
parasitaemia. Thus, malaria infection in HIV infected
subjects in malaria endemic area may not be impli-
cated as contributing adverse effect on some bio-
chemical markers in HIV co-infected subjects.
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